Data from designated brain regions from the cFOS 3D brain imaging study were analysed using one-way ANOVA with Dunnets post hoc multiple-comparison test relative to the vehicle, using a negative binomial generalized linear model to control for Gaussian distribution
Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023
Have you noticed trends or changes in menstrual cycle patterns among users who take GLP-1s
It has been shown that GLP-1R level is decreased in some injured cells, such as in human and mouse hepatocytes of individuals with non-alcoholic steatohepatitis 26,27
Avoiding fat tissue changes (lipodystrophy): Lumps, bumps, or depressions can develop under the skin if injections are not rotated
It's worth noting that not everyone is a candidate for such an invasive procedureand our CT weight loss injections can help you achieve those goals without surgery
